Suc-Phe-pNA is a phenylalanine-derived peptide substrate in which the amino acid side chain is part of a short acylated structure and the carboxyl terminus is linked to p-nitroanilide (pNA), forming an amide-based leaving group. The molecule contains an N-acylated (succinyl) amino terminus, a phenylalanine aromatic side chain, and a p-nitroanilide moiety that bears a nitro-substituted aniline aromatic ring, with the stereochemistry not specified in the product name. Suc-Phe-pNA is employed in enzyme activity and substrate specificity assays where cleavage of the amide bond can release the chromophoric p-nitroanilide for spectrophotometric or colorimetric readout, and it is also used as a defined analytical reagent in biochemical method development.
CAT No: CP26851
CAS No:2440-62-2
Synonyms/Alias:4-({1-[(4-nitrophenyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-4-oxobutanoicacid;2440-62-2;Suphepa;4-({1-benzyl-2-[(4-nitrophenyl)amino]-2-oxoethyl}amino)-4-oxobutanoicacid;3-({1-[(4-nitrophenyl)carbamoyl]-2-phenylethyl}carbamoyl)propanoicacid;AC1L2TMD;AC1Q5MEY;MolPort-006-328-934;EINECS219-472-6;AR-1F5466;SBB072392;AKOS015998330;MCULE-5712584632;AM002847;LT00772286;R8086;ST50819523;3B3-050898;(S)-4-((2-((4-Nitrophenyl)amino)-2-oxo-1-(phenylmethyl)ethyl)amino)-4-oxobutyricacid;3-(N-{1-[N-(4-nitrophenyl)carbamoyl]-2-phenylethyl}carbamoyl)propanoicacid;4-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoicacid;Butanoicacid,4-((2-((4-nitrophenyl)amino)-2-oxo-1-(phenylmethyl)ethyl)amino)-4-oxo-,(S)-
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.